Antibodies are essential proteins of the adaptive immune system. The specific binding of the antigen with high affinity, coupled with the potential to further mutate in response to a target makes ...

Therapeutic antibodies are rapidly emerging as the most successful class of biotherapeutics, with their yearly number of regulatory approvals reaching the same levels as the small molecule drugs 1.

Care of patients with systemic immunoglobulin light chain (AL) amyloidosis has undergone transformative changes, leading to marked, steady progress in outcomes for patients over the past four decades.

MM often goes undetected until its later stages because it presents with non-specific symptoms, including fatigue, weight loss, bone pain, and recurrent infections. 2,3 However, better awareness, ...